World Environment Day 2020 - AstraZeneca’s global ‘Ambition Zero Carbon’ strategy to eliminate emissions by 2025 and be carbon negative across the entire value chain by 2030 - supported by local initiatives

  • AstraZeneca Switzerland supports green transportation and offsets 50% of emissions through myClimate carbon offset projects

5 June 2020 – AstraZeneca, a global, science-led biopharmaceutical company supports today's World Environment Day and is taking action to protect our environment as part of its 'Ambition Zero Carbon' strategy. AstraZeneca is pursuing an ambitious programme for zero carbon emissions from its global operations by 2025 and to ensure its entire value chain is carbon negative by 2030, bringing forward decarbonisation plans by more than a decade. AstraZeneca Switzerland is continually driving forward sustainability activities at its headquarters in Baar, in the canton of Zug.

AstraZeneca’s ‘Ambition Zero Carbon’ strategy

With its ‘Ambition Zero Carbon’ strategy, AstraZeneca aims to fulfil its science-based climate targets ahead of schedule. To achieve this, the company will double its energy productivity, use renewable energies to generate electricity and heat, and convert its entire fleet of company cars to electric vehicles five years ahead of schedule. AstraZeneca also commits to launching a next-generation inhaler to treat asthma and chronic obstructive pulmonary disease (COPD) with near-zero global warming potential (GWP) propellants by 2025. The commitments AstraZeneca has made as part of its ‘Ambition Zero Carbon’ strategy will enable an accelerated reduction of the Company’s impact on the climate and inspire collaboration at a global level to effect policy change.”

Sustainability at AstraZeneca Switzerland

In Switzerland, AstraZeneca operates in an office building with the latest "Minergie" technology for sustainable construction, which results in 80% energy savings and 45-100% reduction in CO2 emissions.

Other sustainability projects and initiatives include:

  • Green transportation: We support the use of public transport instead of company cars and convert the entire company car fleet to "green" with hybrid, plug-in and electric vehicles. 50% of current CO2 emissions are offset by myClimate carbon offset projects.
  • Waste reduction: Avoiding, reducing, reusing and recycling are our strategies to increase material efficiency and reduce waste. As an example, no plastic bottles are used at AstraZeneca Switzerland.
  • Voluntary employee engagement: As part of the Share & Care Europe volunteering programme, our employees make a positive impact on the environment, patients and community.

Read more about Sustainability at AstraZeneca in our global Sustainability Report


AstraZeneca (LSE/STO/NYSE: AZN) is a global, science-led biopharmaceutical company that focuses on the discovery, development and commercialisation of prescription medicines, primarily for the treatment of diseases in three therapy areas - Oncology, Cardiovascular, Renal and Metabolism, and Respiratory. Based in Cambridge, UK, AstraZeneca operates in over 100 countries and its innovative medicines are used by millions of patients worldwide.

AstraZeneca in der Schweiz

120 employees are responsible for coordinating business activities in Switzerland. Our location in Baar is furthermore the Headquarters of the Europe & Canada Commercial Regional team and the Europe & International Oncology teams, for which 40 additional employees work in Switzerland. Our most important therapeutic areas are oncology, cardiovascular, renal, metabolic, respiratory and inflammation. To achieve our climate targets ahead of schedule, we are working tirelessly to further reduce CO2 emissions and waste. Following our “Ambition Zero Carbon” strategy, we are transitioning to decarbonised business by taking actions to reduce and ultimately eliminate greenhouse gas emissions. In 2020, AstraZeneca Switzerland was rated by employees as an excellent place to work for the third time in a row and was awarded the external label "Great place to work®".

More information:

Media Department AstraZeneca Switzerland

Tel. +41 (0) 41 725 75 75;
Dr. Angelika März, Corporate Affairs Lead

CH-2597, 06/2020
© 2020 AstraZeneca AG, Neuhofstrasse 34, 6340 Baar. All rights reserved.